Showing 2 results for Disease
Dr. Amy Jenkins joined DARPA as a program manager in the Biological Technologies Office (BTO) in June 2019. Her interests include the development of platforms for combatting infectious disease threats as well as novel manufacturing methods to enable rapid response.
The goal of the NOW program is to develop a mobile medical countermeasure
(MCM) manufacturing platform for use in stabilization and humanitarian
operations to produce, formulate, and package hundreds of doses of nucleic
acid therapeutics (DNA and/or RNA) in less than 24 hours. The developed
platform should be a resilient, mobile, readily accessible nucleic acid MCM
manufacturing capability that enables immediate threat response anywhere the
military operates with minimal user intervention.